Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant
Clinical trial NCT05799079 · TERMINATED
Trial details
- NCT number
- NCT05799079
- Sponsor
- Sanjay Mohan
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2024-09-20
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.